{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:30:01Z","timestamp":1790602201580,"version":"4.1.0"},"reference-count":59,"publisher":"American Association for Cancer Research (AACR)","issue":"20","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA211024-01A1"],"award-info":[{"award-number":["P50 CA211024-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA241486-01A1"],"award-info":[{"award-number":["R37CA241486-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA272390-01"],"award-info":[{"award-number":["P50 CA272390-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2210197"],"award-info":[{"award-number":["W81XWH2210197"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["23YOUN15"],"award-info":[{"award-number":["23YOUN15"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R25CA221738"],"award-info":[{"award-number":["R25CA221738"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-1-0653"],"award-info":[{"award-number":["W81XWH-17-1-0653"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Histologic transformation of prostate cancer from adenocarcinoma to neuroendocrine prostate cancer (NEPC) is associated with aggressive disease and poor prognosis. This lineage transition is accompanied by polycomb complex 2\u2013mediated epigenetic derepression of cell fate\u2013determining transcription factors, including prospero homeobox 1 (PROX1). In this study, we sought to functionally characterize the role of PROX1 in NEPC. An unbiased CRISPR screen in two NEPC patient-derived organoid models demonstrated high cellular dependency for PROX1. Knockout of PROX1 impeded tumor growth in NEPC models, and overexpression of PROX1 promoted tumor growth and spontaneous metastasis in prostate adenocarcinoma. Transcriptomic and cistromic analyses across castration-resistant adenocarcinoma and neuroendocrine models pointed to PROX1-mediated regulation of neuroendocrine-lineage transcriptional programs. Immunoprecipitation followed by mass spectrometry identified three phosphorylated sites in the DNA-binding domain of PROX1 that are critical for its stability and function. CHEK1 and CDK2 were predicted to be upstream kinases that phosphorylate PROX1, and treatment with a CHEK1 or CDK2 inhibitor reduced NEPC viability. Together, these results substantiate the role of PROX1 in NEPC and identify PROX1 phosphorylation in the DNA-binding domain, which might represent a therapeutic target in NEPC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>PROX1 mediates lineage reprogramming, tumor growth, and metastasis in neuroendocrine prostate cancer and represents a cellular dependency that can be exploited for targeted treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-25-0636","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T14:48:49Z","timestamp":1755787729000},"page":"3842-3854","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression"],"prefix":"10.1158","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-4584","authenticated-orcid":false,"given":"Varadha Balaji","family":"Venkadakrishnan","sequence":"first","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."},{"name":"3The Broad Institute of MIT and Harvard, Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-9334","authenticated-orcid":false,"given":"Adam","family":"Presser","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2702-803X","authenticated-orcid":false,"given":"Nathaniel C.E.","family":"Voss","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"4Belmont Hill School, Belmont, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4135-6479","authenticated-orcid":false,"given":"James","family":"Neiswender","sequence":"additional","affiliation":[{"name":"3The Broad Institute of MIT and Harvard, Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6131-062X","authenticated-orcid":false,"given":"Lisa","family":"Brenan","sequence":"additional","affiliation":[{"name":"3The Broad Institute of MIT and Harvard, Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9120-9659","authenticated-orcid":false,"given":"Keira Prenza","family":"Sosa","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"5KIPP Academy Lynn Collegiate, Lynn, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4813-5308","authenticated-orcid":false,"given":"Kenny","family":"Weng","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8817-6331","authenticated-orcid":false,"given":"Andres M.","family":"Acosta","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2857-4685","authenticated-orcid":false,"given":"Francisca","family":"Vazquez","sequence":"additional","affiliation":[{"name":"3The Broad Institute of MIT and Harvard, Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3259-2226","authenticated-orcid":false,"given":"Himisha","family":"Beltran","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."},{"name":"3The Broad Institute of MIT and Harvard, Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"2025102312211429700_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"2025102312211429700_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2025102312211429700_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1158\/1541-7786.MCR-23-0045","article-title":"Significance of RB loss in unlocking phenotypic plasticity in advanced cancers","volume":"21","author":"Venkadakrishnan","year":"2023","journal-title":"Mol Cancer Res"},{"key":"2025102312211429700_bib4","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2025102312211429700_bib5","first-page":"232","article-title":"Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"22","author":"Huggins","year":"1972","journal-title":"CA Cancer J Clin"},{"key":"2025102312211429700_bib6","doi-asserted-by":"crossref","first-page":"a030452","DOI":"10.1101\/cshperspect.a030452","article-title":"Androgen signaling in prostate cancer","volume":"7","author":"Dai","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025102312211429700_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc801","article-title":"A history of prostate cancer treatment","volume":"2","author":"Denmeade","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2025102312211429700_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2025102312211429700_bib9","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025102312211429700_bib10","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1158\/1078-0432.CCR-19-1423","article-title":"The role of lineage plasticity in prostate cancer therapy resistance","volume":"25","author":"Beltran","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2025102312211429700_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41585-019-0237-8","article-title":"Towards precision oncology in advanced prostate cancer","volume":"16","author":"Ku","year":"2019","journal-title":"Nat Rev Urol"},{"key":"2025102312211429700_bib12","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025102312211429700_bib13","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","article-title":"The transcriptional and epigenetic landscape of cancer cell lineage plasticity","volume":"13","author":"Davies","year":"2023","journal-title":"Cancer Discov"},{"key":"2025102312211429700_bib14","doi-asserted-by":"crossref","first-page":"eabe1505","DOI":"10.1126\/science.abe1505","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science"},{"key":"2025102312211429700_bib15","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1038\/s41591-023-02605-z","article-title":"Liquid biopsy epigenomic profiling for cancer subtyping","volume":"29","author":"Baca","year":"2023","journal-title":"Nat Med"},{"key":"2025102312211429700_bib16","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1038\/s41467-021-26042-z","article-title":"Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer","volume":"12","author":"Cejas","year":"2021","journal-title":"Nat Commun"},{"key":"2025102312211429700_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.stem.2014.05.006","article-title":"Chromatin repressive complexes in stem cells, development, and cancer","volume":"14","author":"Laugesen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"2025102312211429700_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1101\/gad.381706","article-title":"Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions","volume":"20","author":"Bracken","year":"2006","journal-title":"Genes Dev"},{"key":"2025102312211429700_bib19","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1038\/s41467-024-51156-5","article-title":"Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes","volume":"15","author":"Venkadakrishnan","year":"2024","journal-title":"Nat Commun"},{"key":"2025102312211429700_bib20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat Med"},{"key":"2025102312211429700_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.bjc.6690684","article-title":"Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system","volume":"81","author":"Culig","year":"1999","journal-title":"Br J Cancer"},{"key":"2025102312211429700_bib22","first-page":"2913","article-title":"Establishment and identification of small cell lung cancer cell lines having classic and variant features","volume":"45","author":"Carney","year":"1985","journal-title":"Cancer Res"},{"key":"2025102312211429700_bib23","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jnci\/81.16.1223","article-title":"Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies","volume":"81","author":"Johnson","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"2025102312211429700_bib24","first-page":"225","article-title":"Molecular genetic characterization of neuroendocrine lung cancer cell lines","volume":"15","author":"Lai","year":"1995","journal-title":"Anticancer Res"},{"key":"2025102312211429700_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/pros.10290","article-title":"Molecular characterization of human prostate carcinoma cell lines","volume":"57","author":"van Bokhoven","year":"2003","journal-title":"Prostate"},{"key":"2025102312211429700_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1593\/neo.07103","article-title":"Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model","volume":"9","author":"Mertz","year":"2007","journal-title":"Neoplasia"},{"key":"2025102312211429700_bib27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2016.03.001","article-title":"N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells","volume":"29","author":"Lee","year":"2016","journal-title":"Cancer Cell"},{"key":"2025102312211429700_bib28","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41467-018-04495-z","article-title":"Patient derived organoids to model rare prostate cancer phenotypes","volume":"9","author":"Puca","year":"2018","journal-title":"Nat Commun"},{"key":"2025102312211429700_bib29","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"2025102312211429700_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41587-020-0600-6","article-title":"Optimization of AsCas12a for combinatorial genetic screens in human cells","volume":"39","author":"DeWeirdt","year":"2021","journal-title":"Nat Biotechnol"},{"key":"2025102312211429700_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13059-021-02540-7","article-title":"Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects","volume":"22","author":"Dempster","year":"2021","journal-title":"Genome Biol"},{"key":"2025102312211429700_bib32","doi-asserted-by":"crossref","first-page":"D729","DOI":"10.1093\/nar\/gky1094","article-title":"Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis","volume":"47","author":"Zheng","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2025102312211429700_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.2930310402","article-title":"Tumor measurement in the nude mouse","volume":"31","author":"Euhus","year":"1986","journal-title":"J Surg Oncol"},{"key":"2025102312211429700_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"2025102312211429700_bib35","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.cell.2016.04.031","article-title":"Acquired tissue-specific promoter bivalency is a basis for PRC2 necessity in adult cells","volume":"165","author":"Jadhav","year":"2016","journal-title":"Cell"},{"key":"2025102312211429700_bib36","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1038\/s41467-020-18377-w","article-title":"Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules","volume":"11","author":"Nabet","year":"2020","journal-title":"Nat Commun"},{"key":"2025102312211429700_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41589-018-0021-8","article-title":"The dTAG system for immediate and target-specific protein degradation","volume":"14","author":"Nabet","year":"2018","journal-title":"Nat Chem Biol"},{"key":"2025102312211429700_bib38","doi-asserted-by":"crossref","first-page":"e185952","DOI":"10.1172\/jci.insight.185952","article-title":"ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer","volume":"9","author":"Nouruzi","year":"2024","journal-title":"JCI Insight"},{"key":"2025102312211429700_bib39","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ccell.2022.10.011","article-title":"FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer","volume":"40","author":"Han","year":"2022","journal-title":"Cancer Cell"},{"key":"2025102312211429700_bib40","doi-asserted-by":"crossref","first-page":"E1936","DOI":"10.1073\/pnas.1421480112","article-title":"SOX2 primes the epigenetic landscape in neural precursors enabling proper gene activation during hippocampal neurogenesis","volume":"112","author":"Amador-Arjona","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025102312211429700_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-05650-9","article-title":"A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature","volume":"614","author":"Kazenwadel","year":"2023","journal-title":"Nature"},{"key":"2025102312211429700_bib42","doi-asserted-by":"crossref","first-page":"e175217","DOI":"10.1172\/JCI175217","article-title":"Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer","volume":"134","author":"Ku","year":"2024","journal-title":"J Clin Invest"},{"key":"2025102312211429700_bib43","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1038\/s41467-024-49234-9","article-title":"FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"2025102312211429700_bib44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.devcel.2021.01.018","article-title":"Beyond PROX1: transcriptional, epigenetic, and noncoding RNA regulation of lymphatic identity and function","volume":"56","author":"Ducoli","year":"2021","journal-title":"Dev Cell"},{"key":"2025102312211429700_bib45","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41586-022-05575-3","article-title":"An atlas of substrate specificities for the human serine\/threonine kinome","volume":"613","author":"Johnson","year":"2023","journal-title":"Nature"},{"key":"2025102312211429700_bib46","first-page":"454","article-title":"Prospero-related homeobox 1 (Prox1) at the crossroads of diverse pathways during adult neural fate specification","volume":"8","author":"Stergiopoulos","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"2025102312211429700_bib47","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.aab0917","article-title":"RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance","volume":"349","author":"Miyamoto","year":"2015","journal-title":"Science"},{"key":"2025102312211429700_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2121-9-4","article-title":"The androgen receptor can signal through Wnt\/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens","volume":"9","author":"Schweizer","year":"2008","journal-title":"BMC Cell Biol"},{"key":"2025102312211429700_bib49","doi-asserted-by":"crossref","first-page":"22189","DOI":"10.1073\/pnas.1906484116","article-title":"Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer","volume":"116","author":"Moparthi","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025102312211429700_bib50","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1158\/0008-5472.CAN-20-3351","article-title":"Activated ALK cooperates with N-Myc via Wnt\/\u03b2-catenin signaling to induce neuroendocrine prostate cancer","volume":"81","author":"Unno","year":"2021","journal-title":"Cancer Res"},{"key":"2025102312211429700_bib51","doi-asserted-by":"crossref","first-page":"217068","DOI":"10.1016\/j.canlet.2024.217068","article-title":"PROX1 drives neuroendocrine plasticity and liver metastases in prostate cancer","volume":"597","author":"Liu","year":"2024","journal-title":"Cancer Lett"},{"key":"2025102312211429700_bib52","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1158\/0008-5472.CAN-13-2921-T","article-title":"High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development","volume":"74","author":"Lin","year":"2014","journal-title":"Cancer Res"},{"key":"2025102312211429700_bib53","doi-asserted-by":"crossref","first-page":"e95996","DOI":"10.1371\/journal.pone.0095996","article-title":"Impact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma","volume":"9","author":"Lv","year":"2014","journal-title":"PLoS One"},{"key":"2025102312211429700_bib54","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/hep.26398","article-title":"PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1\u03b1 expression and protein stability","volume":"58","author":"Liu","year":"2013","journal-title":"Hepatology"},{"key":"2025102312211429700_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2019.08.011","article-title":"Clinical features of neuroendocrine prostate cancer","volume":"121","author":"Conteduca","year":"2019","journal-title":"Eur J Cancer"},{"key":"2025102312211429700_bib56","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s43018-023-00539-6","article-title":"Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer","volume":"4","author":"Bakht","year":"2023","journal-title":"Nat Cancer"},{"key":"2025102312211429700_bib57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccr.2008.02.020","article-title":"Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype","volume":"13","author":"Petrova","year":"2008","journal-title":"Cancer Cell"},{"key":"2025102312211429700_bib58","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41586-024-08150-0","article-title":"Progressive plasticity during colorectal cancer metastasis","volume":"637","author":"Moorman","year":"2024","journal-title":"Nature"},{"key":"2025102312211429700_bib59","doi-asserted-by":"crossref","first-page":"102953","DOI":"10.1016\/j.isci.2021.102953","article-title":"ASCL1, NKX2-1, and PROX1 co-regulate subtype-specific genes in small-cell lung cancer","volume":"24","author":"Pozo","year":"2021","journal-title":"iScience"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-0636\/3644153\/can-25-0636.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-0636\/3656011\/can-25-0636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/20\/3842\/3658457\/can-25-0636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/85\/20\/3842\/3658457\/can-25-0636.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:21:30Z","timestamp":1761236490000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/85\/20\/3842\/766086\/Epigenetic-Derepression-of-PROX1-Promotes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":59,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2025,8,21]]},"published-print":{"date-parts":[[2025,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-25-0636","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.30418257","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30429349","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30418245","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30429337","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30363234","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30418251","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30363258","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30363246","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30418263","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30363252","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30363240","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30429352","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30429340","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30418248","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30418266","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30429358","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30363237","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30418254","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30429346","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30363255","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30418242","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30363243","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30418260","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30363231","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30429361","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30429343","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30429355","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8090676","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}